Dose Prescription to Isodose Lines in Static Multi-Beam Stereotactic Body Radiotherapy for Lung Tumors: Which Line Is Optimal?

dose prescription isodose line lung static multi-beam stereotactic body radiotherapy treatment planning

Journal

The Kurume medical journal
ISSN: 1881-2090
Titre abrégé: Kurume Med J
Pays: Japan
ID NLM: 2985210R

Informations de publication

Date de publication:
16 Jan 2024
Historique:
medline: 18 1 2024
pubmed: 18 1 2024
entrez: 17 1 2024
Statut: aheadofprint

Résumé

This study investigated the appropriate dose prescription method in static multi-beam stereotactic body radiotherapy for lung tumors. Static multi-beam stereotactic body radiotherapy is a mainstream treatment in Japan. Based on the hypothesis that dose prescription to lower isodose lines may improve planning target volume dose coverage and decrease doses to organs at risk, we investigated changes in dose-volume histograms with prescription to various isodose lines for planning target volume in static multi-beam stereotactic body radiotherapy. In all treatment plans, 45 Gy in 4 fractions were prescribed to 95% of the planning target volume. By adjusting the leaf margins of each beam, various prescription isodose lines encompassing 95% volume of the planning target volume were generated. The prescription isodose lines investigated were 40, 50, 60, 70, 80 and 90% lines relative to the maximum dose of each planning target volume. The conformity index, homogeneity index, mean lung dose, and V5-V40 of the lung were evaluated. The dose was calculated by the adaptive convolve algorithm. The conformity index was lowest in the 70% or 80% isodose plan. The mean lung doses and V10-V40 of the lung decreased steeply from the 90% to the 70% isodose plan, and was lowest in the 60% and 70% isodose plans. These indices increased in the 40% and 50% isodose plans. The optimal stereotactic body radiotherapy plans appeared to be dose prescription to the 60% or 70% isodose line. Further investigation is warranted to clarify the advantage of using this method clinically.

Identifiants

pubmed: 38233174
doi: 10.2739/kurumemedj.MS6934016
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Maho Iwana-Yamada (M)

Department of Radiotherapy, Nagoya Proton Therapy Center.
Department of Radiology, Nagoya City University Graduate School of Medical Sciences.

Yuta Shibamoto (Y)

Department of Radiology, Nagoya City University Graduate School of Medical Sciences.

Fumiya Baba (F)

Department of Radiotherapy, Nagoya Proton Therapy Center.
Department of Radiology, Nagoya City University Graduate School of Medical Sciences.

Hiromitsu Iwata (H)

Department of Radiation Oncology, Nagoya Proton Therapy Center.
Department of Radiology, Nagoya City University Graduate School of Medical Sciences.

Satoshi Ishikura (S)

Department of Radiology, Nagoya City University Graduate School of Medical Sciences.

Junpei Nagayoshi (J)

Department of Radiological Technology, Nagoya City University West Medical Center.

Akio Hiwatashi (A)

Department of Radiology, Nagoya City University Graduate School of Medical Sciences.

Hiroyuki Ogino (H)

Department of Radiation Oncology, Nagoya Proton Therapy Center.
Department of Radiology, Nagoya City University Graduate School of Medical Sciences.

Classifications MeSH